PI
AMED

PEAK6 Investments’s Amedisys AMED Stock Holding History

PEAK6 Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,400
Closed -$523K – 4362
2022
Q3 		$523K Buy
5,400
+2,400
+80% +$286K ﹤0.01% 2833
2022
Q2 		$315K Sell
3,000
-53,900
-95% -$6.89M ﹤0.01% 4306
2022
Q1 		$9.8M Buy
+56,900
New +$8.5M 0.02% 709
2021
Q4 		– Sell
-22,800
Closed -$3.4M – 5045
2021
Q3 		$3.4M Buy
22,800
+4,600
+25% +$956K 0.01% 1459
2021
Q2 		$4.46M Buy
18,200
+4,400
+32% +$1.15M 0.01% 1198
2021
Q1 		$3.65M Sell
13,800
-26,400
-66% -$7.45M 0.01% 1308
2020
Q4 		$11.8M Sell
40,200
-9,000
-18% -$2.31M 0.02% 597
2020
Q3 		$11.6M Sell
49,200
-10,500
-18% -$2.39M 0.03% 518
2020
Q2 		$11.9M Buy
59,700
+14,500
+32% +$2.7M 0.04% 426
2020
Q1 		$8.3M Sell
45,200
-14,600
-24% -$2.6M 0.05% 362
2019
Q4 		$9.98M Buy
59,800
+50,600
+550% +$7.53M 0.05% 372
2019
Q3 		$1.21M Buy
9,200
+5,700
+163% +$742K 0.01% 1618
2019
Q2 		$425K Buy
+3,500
New +$415K ﹤0.01% 2388
2019
Q1 		– Sell
-29,900
Closed -$3.5M – 3755
2018
Q4 		$3.5M Buy
29,900
+14,100
+89% +$1.66M 0.02% 860
2018
Q3 		$1.97M Buy
+15,800
New +$1.74M 0.01% 1432

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PEAK6 Investments's AMED Position: Q1 2022 in Review

PEAK6 Investments sold out of Amedisys (AMED) in Q1 2022, closing a stake of 12,486 shares — an estimated $1.87M sold.

PEAK6 Investments first reported a position in AMED in Q4 2018 and held it in 9 quarters. The position peaked at $7.96M in Q3 2021. 329 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

  • PEAK6 Investments reported no remaining Amedisys position as of Q1 2022 after selling out during the quarter.
  • PEAK6 Investments sold 12,486 Amedisys shares in Q1 2022, an estimated $1.87M.
  • PEAK6 Investments first reported a position in Amedisys in Q4 2018 and held it in 9 quarters.
  • PEAK6 Investments's Amedisys position peaked at $7.96M in Q3 2021.
  • 329 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on PEAK6 Investments's 13F filing for Q1 2022, filed 13 May 2022.